miR-503-5p inhibits adipogenesis by targeting bmpr1a in C3H10T1/2 cells [58], miR-135a-5p suppresses adipogenes by activating the canonical Wnt/β-catenin signaling in 3T3-L1 cells [59], and miR-19a-3p acts as a serum miRNAs biomarker for pancreatic cancer-associated new-onset diabetes mellitus [60] and it is also involved in C3H10T1/2 chondrogenic differentiation [61]. Here, BMPR1A is linked to pancreatic neoplasm.